5,370
Total Claims
$2.9M
Drug Cost
968
Beneficiaries
$3,011
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-41%
Cost per patient vs peers
$3,011 vs $5,138 avg
-6%
Brand preference vs peers
57.8% vs 61.4% avg
Brand vs Generic
42% generic
Brand: 3,096 claims · $2.8M
Generic: 2,261 claims · $135K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 61 | $807K |
| Fluticasone/Umeclidin/Vilanter | 631 | $584K |
| Budesonide/Glycopyr/Formoterol | 293 | $216K |
| Umeclidinium Brm/Vilanterol Tr | 268 | $161K |
| Tiotropium Bromide | 180 | $148K |
| Alpha-1-Proteinase Inhibitor | 12 | $145K |
| Fluticasone/Vilanterol | 223 | $112K |
| Tiotropium Br/Olodaterol Hcl | 128 | $106K |
| Budesonide/Formoterol Fumarate | 140 | $83K |
| Fluticasone Propion/Salmeterol | 105 | $53K |
| Tiotropium Bromide | 44 | $46K |
| Fluticasone Propion/Salmeterol | 71 | $44K |
| Fluticasone Furoate | 96 | $31K |
| Apixaban | 40 | $29K |
| Fluticasone Propion/Salmeterol | 98 | $27K |
Prescribing Profile
50
Unique Drugs
Patient Profile
75
Avg Age
62%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About